[1]
Lima, M., Dutra, S., Gomes, F.V., Bilhim, T. and Coimbra, Élia 2018. Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment. Acta Médica Portuguesa. 31, 1 (Jan. 2018), 22–29. DOI:https://doi.org/10.20344/amp.8976.